Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxervate in Severe Sjogren's Dry Eye Disease
NCT05133180Phase 3Completed
- Sponsor
- Dompé
- Start
- Jan 2022
- Primary completion
- Sep 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of cenegermin in dry eye syndrome (DED), sponsored by Dompé. Started Jan 2022; status: completed.
02
Drugs
cenegermin
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT05133180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05133180.